Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing safety, tolerability, drug levels and effects of BMS-986326 in adults with lupus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BMS-986326

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lupus | Phase 1 | Status: RECRUITING